NIGERIA

Nigeria Confirms Imported Ebola Case as WHO Urges Calm, 44 Contacts Monitored

Nigeria has confirmed an imported case of Ebola Bundibugyo virus disease in the Federal Capital Territory (FCT), prompting intensified public health surveillance as authorities work to prevent further transmission.

The World Health Organization (WHO) has urged Nigerians to remain calm, emphasising that the detection of a single imported case does not, in itself, mean the country is experiencing an Ebola outbreak.

The development was confirmed by the Federal Government on 20 October 2026, following laboratory testing of a woman with a recent travel history involving Uganda. The patient is currently receiving medical care in isolation, while investigations continue to establish where she was exposed to the virus.

According to the WHO, the patient’s symptoms began on 7 October, four days after her arrival in Nigeria. She sought medical attention at a private health facility in Abuja on 11 October, before laboratory confirmation was obtained on 20 October.

Health authorities have identified 44 contacts who are being monitored as part of efforts to determine whether anyone else may have been exposed. Investigations are also examining the patient’s movements and potential points of contact, while infection prevention measures have been strengthened at the facility where she initially received treatment.

The Nigeria Centre for Disease Control and Prevention (NCDC) has activated its incident management system to coordinate the national response. The WHO and other partners are supporting Nigerian authorities with case investigations, contact tracing, laboratory capacity and measures designed to protect healthcare workers and the wider population.

The confirmed infection comes amid an ongoing outbreak of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo (DRC), with related cases reported in other countries. However, the precise circumstances surrounding the Nigerian patient’s infection remain under investigation.

Uganda’s health authorities have also clarified that the patient’s passage through the country does not establish that she contracted the virus there. The location of exposure remains a matter for the ongoing investigation.

The WHO has stressed the importance of early detection, effective contact tracing and strict infection prevention procedures in containing the disease. It has also advised against imposing travel or trade restrictions on affected countries, stating that the public health response should be guided by the evolving evidence and official risk assessments.

Ebola is a serious viral disease that can cause symptoms including fever, weakness, headache, muscle pain and sore throat, followed in some cases by vomiting, diarrhoea and other severe complications. Transmission occurs through direct contact with the blood or other bodily fluids of an infected person who is symptomatic, or with contaminated materials.

The virus does not spread simply because people share the same public space. Nevertheless, anyone who develops concerning symptoms after a possible exposure should seek prompt medical assessment and disclose relevant travel or contact history to healthcare professionals.

Nigeria’s experience managing the 2014 Ebola outbreak provides an important foundation for its current response. The effectiveness of the measures now under way will depend on timely identification of possible cases, careful monitoring of contacts, transparent communication and the cooperation of healthcare facilities and the public.

For now, the immediate priority is to contain the confirmed infection, complete the necessary investigations and establish whether any additional cases have occurred. Nigerians are encouraged to rely on official updates from the NCDC, the Federal Ministry of Health and Social Welfare, and the WHO rather than unverified social media claims.

As investigations continue, the authorities’ ability to identify potential exposures quickly and sustain effective surveillance will be central to limiting the risk of further transmission.